סיטרבין להזרקה 1 גרם USP

Land: Israel

Sprog: hebraisk

Kilde: Ministry of Health

Aktiv bestanddel:

CYTARABINE 1 G/VIAL

Tilgængelig fra:

GENMEDIX

ATC-kode:

L01BC01

Lægemiddelform:

POWDER FOR SOLUTION FOR INJECTION

Indgivelsesvej:

I.V, S.C, INTRATRACHEAL

Fremstillet af:

BEN VENUE LABORATORIES INC,USA

Terapeutisk gruppe:

CYTARABINE

Terapeutiske indikationer:

Cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non-lymphcytic leukemia of adults and children. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of cytarabine is indicated in the prophylaxis and treatment of meningeal leukemia.

Autorisation dato:

2008-12-01